Page last updated: 2024-10-24

verapamil and Agammaglobulinemia

verapamil has been researched along with Agammaglobulinemia in 1 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Agammaglobulinemia: An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood.

Research Excerpts

ExcerptRelevanceReference
"We report a case of fulminating systemic capillary leak syndrome which temporarily responded to verapamil, a calcium channel blocker."3.69Fulminating systemic capillary leak syndrome with lymphocytosis and hypogammaglobulinemia. ( Hays, RM; Kang, PM; Khan, GA; Lawrence, C, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kang, PM1
Lawrence, C1
Khan, GA1
Hays, RM1

Other Studies

1 other study available for verapamil and Agammaglobulinemia

ArticleYear
Fulminating systemic capillary leak syndrome with lymphocytosis and hypogammaglobulinemia.
    Renal failure, 1995, Volume: 17, Issue:5

    Topics: Agammaglobulinemia; Calcium Channel Blockers; Capillary Permeability; Humans; Lymphocytosis; Male; M

1995